Use of Molecular Markers for Cytologically Indeterminate Thyroid Nodules to Optimize Surgical Management

被引：0
|
作者：
Yip, Linwah [1 ]
机构：
[1] Univ Pittsburgh, Dept Surg, Div Endocrine Surg & Surg Oncol, Suite 101,3471 Fifth Ave, Pittsburgh, PA 15213 USA
来源：
CURRENT SURGERY REPORTS | 2014年 / 2卷 / 01期
关键词：
Thyroid nodule; Thyroid cancer; Thyroidectomy; Molecular markers; Mutation testing; Indeterminate biopsy; Surgical management; MicroRNA; Rearrangements;
D O I：
10.1007/s40137-013-0035-9
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The management of thyroid nodules with indeterminate cytology has traditionally been diagnostic thyroidectomy. However most nodules are benign, and for nodules that demonstrate histologic malignancy, two-stage thyroidectomy may be necessary. Molecular markers have emerged as an adjunct to preoperative FNAB cytology evaluation that can improve diagnostic accuracy. In this review, we discuss the latest methodologies and review diagnostic performance parameters of recent molecular marker techniques.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Use of Molecular Markers for Cytologically Indeterminate Thyroid Nodules to Optimize Surgical Management
    Linwah Yip
    Current Surgery Reports, 2 (1)
  • [2] Surgical management of cytologically indeterminate thyroid nodules
    Almquist, Martin
    Muth, Andreas
    GLAND SURGERY, 2019, 8 : S105 - S111
  • [3] Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules
    Valderrabano, Pablo
    Khazai, Laila
    Thompson, Zachary J.
    Leon, Marino E.
    Otto, Kristen J.
    Hallanger-Johnson, Julie E.
    Wadsworth, J. Trad
    Chung, Christine H.
    Centeno, Barbara A.
    McIver, Bryan
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (08): : 1812 - 1823
  • [4] Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
    Goldner, Whitney S.
    Angell, Trevor E.
    McAdoo, Sallie Lou
    Babiarz, Joshua
    Sadow, Peter M.
    Nabhan, Fadi A.
    Nasr, Christian
    Kloos, Richard T.
    THYROID, 2019, 29 (11) : 1594 - 1605
  • [5] OVERVIEW OF MOLECULAR BIOMARKERS FOR ENHANCING THE MANAGEMENT OF CYTOLOGICALLY INDETERMINATE THYROID NODULES AND THYROID CANCER
    Duick, Daniel S.
    ENDOCRINE PRACTICE, 2012, 18 (04) : 611 - 615
  • [6] Molecular Markers in the Diagnosis of Thyroid Cancer in Indeterminate Thyroid Nodules
    Kannan, Subramanian
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2022, 13 (01) : 11 - 16
  • [7] Molecular Markers in the Diagnosis of Thyroid Cancer in Indeterminate Thyroid Nodules
    Subramanian Kannan
    Indian Journal of Surgical Oncology, 2022, 13 : 11 - 16
  • [8] Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
    Chin, Patrick D.
    Zhu, Catherine Y.
    Sajed, Dipti P.
    Fishbein, Gregory A.
    Yeh, Michael W.
    Leung, Angela M.
    Livhits, Masha J.
    ENDOCRINE PATHOLOGY, 2020, 31 (04) : 377 - 384
  • [9] Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
    Patrick D. Chin
    Catherine Y. Zhu
    Dipti P. Sajed
    Gregory A. Fishbein
    Michael W. Yeh
    Angela M. Leung
    Masha J. Livhits
    Endocrine Pathology, 2020, 31 : 377 - 384
  • [10] SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodules
    Lasolle, Helene
    Lopez, Jonathan
    Pattou, Francois
    Borson-Chazot, Francoise
    Bardet, Stephane
    Groussin, Lionel
    Buffet, Camille
    ANNALES D ENDOCRINOLOGIE, 2022, 83 (06) : 395 - 400
12345